At the 2025 ASCO® Annual Meeting, three of Inizio's experts, including Inizio Evoke's Chief Medical Officer, Matthew Hoelzle, sat down with OncoDaily to share their unique perspectives in oncology – from amplifying the patient voice to unlocking real-world impact through data and AI. Watch Matthew's interview below and check out other expert perspectives here.
Interesting in hearing more key takeaways and expert insights from ASCO® 2025?
Join us on on June 24 at 10am ET / 3pm BST for an insider’s perspective on ASCO 2025 - where innovation, investment, and impact converged. With congresses ranking among the most substantial marketing and engagement investments for life sciences organizations, focusing solely on execution is no longer enough - outcomes must take center stage. Drawing from our experience supporting multiple clients with hundreds of assets and numerous booths, our multidisciplinary team has had a unique vantage point on the evolving congress landscape.
From the growing emphasis on sustainability and AI to the adoption of immersive technologies and a more strategic approach to scientific storytelling, we’ll explore the reasoning behind emerging trends to help you craft more impactful engagement strategies. This isn’t your typical recap - it’s an insider’s perspective on the insights, innovations, and strategic choices that drove measurable value, as told by the experts who brought them to life.
The panel will feature speakers from across Inizio, including Patty Zipfel, SVP, Scientific Strategy at Inizio Evoke, who will share their perspectives on creating smarter, more effective congress engagements.
Drawing on Inizio's unmatched oncology expertise - spanning more than 140 early-phase assets and 95% of the top 20 oncology products - we’ll go beyond the obvious to surface the trends, directional shifts, and implications you might have missed.
Don’t miss your chance to get ahead of what’s next in oncology. Register here to secure your spot.